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Abstract. Forty patients with late-onset diabetes (age at 
diagnosis 30 years or more) and minimal retinopathy 
as found by fundus photography were followed prospec- 
tively by repeated examination (baseline, 1 year, and 
4 years). The study shows that early retinopathy changes 
are not permanent or invariably progressive. In the 
1st year of follow-up microaneurysms worsened in 25%, 
improved in 10%, and remained stabilized in 65%. Vit- 
reous fluorometry was able to detect an overall increase 
of 0.84_+1.06 x 10 -6  min -1 in blood-retinal barrier 
(BRB) penetration ratios. After 4 years, 16 of the 40 
patients had undergone photocoagulation (focal photo- 
coagulation in 11 and pan retinal photocoagulation i  
5). The eyes that needed photocoagulation were the eyes 
that had higher fluorometry penetration ratios at the 
patient's entry into the study and showed a higher rate 
of deterioration during the 1st year of the study (5.54_+ 
1.97 vs 3 .11_ l .22x10-6min  -a, P<0.001, initial 
values; 1.52_+0.76 vs 0.45+_0.99x10 -6 min -a, P< 
0.001, annual increase in leakage). The eyes that did 
not need photocoagulation, 24 out of 40, showed stable 
fluorometry readings within the 4-year period of follow- 
up (+0.02_+0.98 10 -6  min-1). Abnormally high vitre- 
ous fluorometry values and their rapid increase over time 
appear to be good indicators of rapid progression and 
worsening of the retinopathy. 
Introduction 
Retinopathy is a frequent microvascular complication 
of diabetes mellitus. At present, the only proven treat- 
ment is photocoagulation [6]. This is, however, a de- 
structive treatment and is not always effective. Future 
developments in the prevention and treatment of diabet- 
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ic retinopathy will depend on a better understanding 
of the evolution of the early changes that occur in the 
retina, when they may still be reversible. 
The initial changes occurring in the diabetic retina 
are characteristically located in the small retinal vessels 
of the posterior pole of the retina, in the macular area. 
These are capillary closure in the arterial side of the 
capillary net and microaneurysm formation in the ve- 
nous side [1]. Fluorescein angiography demonstrates 
particularly well these early changes and the associated 
alteration of the blood-retinal barrier (BRB). This last 
alteration may also be quantified, in a reproducible man- 
ner, by vitreous fluorometry. 
Using fluorescein angiography and vitreous fluoro- 
metry we evaluated prospectively a series of patients 
with adult onset diabetes mellitus and moderate or no 
retinopathy. The patients were examined at entry into 
the study, 1 year after the initial examination, and reexa- 
mined at the end of 4 years. A need for photocoagula- 
tion as determined by preestablished guidelines was con- 
sidered a primary outcome indicating worsening of the 
retinopathy. 
Materials and methods 
Forty patients with adult-onset diabetes, type 2 (age at diagnosis 
30 years or more, with retinopathy no greater then level 3 of the 
modified Airlie House Classification [5] in the macular area) com- 
pleted the study. Forty-three patients were initially enrolled but 
three did not complete the 1st year of follow-up and were excluded. 
Thereafter there were no more losses to follow-up. Excluded from 
the study were patients with the following conditions: more than 
level 3 of the modified Airlie House classification of diabetic retino- 
pathy in the macular field; vitreous pathology; cloudy ocular me- 
dia or refraction greater than 5 diopters; vascular, neurological, 
or dermatological complications of diabetes, heart disease, or hy- 
pertension (diastolic blood pressure greater than 90 mmHg or sys- 
tolic blood pressure greater than 160 mmHg). The retinopathy ex- 
clusion criteria determined that the eyes to be included in the study 
should have not more microaneurysms and hemorrhages than ref- 
erence photograph 2 A, no more exudates than in reference photo- 
graph 3, and no evidence of IRMAs (Intraretinal microvascutar 
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abnormalities) or cotton-wool spots [1]. Only one eye per patient 
was included in the study and this was called the study eye. As 
stated previously, only patients without clinically significant macu- 
lar edema nd with no signs of neovascularization were enrolled 
in the study. 
Visual acuity testing, slip-lamp biomicroscopy, ophthalmos- 
copy, fundus photography, fluorescein angiography, and vitreous 
fluorometry were performed on entry into the study and 1 and 
4 years later, within a period of 44-52 months after the initial 
examination. During this period of 4 years the patients were reexa- 
mined at 6-month intervals by slit-lamp biomicroscopy and oph- 
thalmoscopy. Photocoagulation was performed by the attending 
doctor whenever it was considered to be needed and following 
preestablished guidelines. The guidelines for photocoagulation 
were that focal photocoagulation was performed whenever a diag- 
nosis of clinically significant macular edema was made. Clinically 
significant macular edema was diagnosed when retinal thickening 
at or within 500 gm of the center of the macula nd or hard exu- 
dates associated with thickening of the adjacent retina were seen 
on slip-lamp examination. Panretinal photocoagulation was per- 
formed whenever the ophthamological examination showed clear 
evidence of neovascularization involving the optic disk. This diag- 
nosis was always confirmed by fluorescein angiography. 
On the 4-year examination vitreous fluorometry was only per- 
formed in patients who had not undergone photocoagulation. 
The 40 patients covered an age range of 40-65 years and all 
had had diabetes for more than 4 years at the start of the study 
(mean age 53.9 _+ 7.3 years, mean diabetes duration 9.9 +4.7 years). 
The patients here reported were followed closely by the Dia- 
betes Clinic and remained within the limits of acceptably good 
control. Their data in relation to diabetes duration, glycated hemo- 
globin, and fasting blood glucose levels are presented in Table 1. 
Approval for the study was obtained from the Ethics Committee 
of the Coimbra University Hospital and all patients gave informed 
consent prior to enrolment. 
Retinopathy grading 
After maximal dilation of the pupil fundus, photographs were tak- 
en of both eyes in fields 1 and 2 as defined by the Diabetic Retino- 
pathy Study [3]. A solution of 20% sodium fluorescein (14 mg 
per kilogram body weight) was then injected intravenously. The 
fluorescein angiography was performed according to a set protocol. 
A series of 20 photographs of field 2 of the study eye were started 
before the capillary phase of the angiogram. A sequence of four 
photographs of field 2 were also performed after 50 s. At 1 rain, 
stereophotographs of fields 1 and 2 were taken of both eyes. Late 
photographs (10 min) were again taken of the study eye. 
Microaneurysms were evaluated on fluorescein angiography, 
according to a semiquantitative grading system, Microaneurysms 
were classified according to presence and number in the macular 
area into four categories: absent or questionable; 1:1-5 microan- 
eurysms; 2:5-10 microaneurysms; 3: more than 10 microaneur- 
ysms. The evaluation was performed by two senior ophthalmolo- 
gists who did not know to whom the angiograms belonged. 
Ocular fluorometry examinations 
The measurements were made with a commercial f uorophot- 
ometer, the Fluorotron Master TM. Details of the procedure have 
been previously described [5]. Scans were taken before the adminis- 
tration of 14 mg fluorescein/kg body weight and 60 min after injec- 
tion. The fluorophotometric data were saved on magnetic diskettes 
and then processed to correct he influence of the autofluorescence 
and to provide the numerical values of the amount of fluorescein 
that had penetrated into the vitreous. This subtraction minimizes 
the contribution of natural fluorescence, mainly that of the lens. 
Based on previous experience we estimated the mean of the mea- 
sure between 2 and 4 mm to obtain posterior vitreous values 
(Pv2-4). We then proceeded to determine the penetration ratio 
(VFPR) which reflects the blood-retinal barrier permeability by 
using the following formula: 
Pv2 - 4 (60') - Pv2 - 4 (0') 
VFPR = Plasma fluorescein integral (3-60') 
The normal value of the vitreous fluorometry penetration ratio 
in a series of 22 persons below 60 years is 2.7+0.8 x 10 6 min-1 
(mean+2SD: 4.3 x •0 .6 min-1). This value is apparently not in- 
fluenced by age or refraction. Reproducibility of vitreous fluoro- 
metry is 12% [10]. 
Plasma fluorescein measurements 
The decay of plama fluorescein was expressed as a logarithmic 
function: log (plasma concentration)= a+b+log(t), where a and 
b are constants hat can be determined by two or more measure- 
ments and t is the time after injection. All the technical procedures 
have been described in detail elsewhere [3]. We collected blood 
samples on which we performed measurements at 10, 15, and 
50 min. 
Evaluation parameters and statistic 
The purpose of the study was to compare initial permeability values 
and the longterm clinical course. As parameter for evaluation of 
the clinical courses need for photocoagulation was chosen. Data 
were analyzed using the one-way ANOVA (analyses of variance) 
and the unpaired Student's t test. 
Results 
BRB permeability, initial values and characterization of 
the patient group 
Table 1 shows the results of fasting blood glucose and 
hemoglobin (HFbA1)  in relation to durat ion of diabetes. 
It shows that the majority of patients enrolled in the 
study had had known diabetes for up to 10 years. The 
durat ion groups show comparable l vels of fasting blood 
glucose and HbA1. 
The vitreous f luorometry penetrat ion ratios (VFPR) 
at entry are presented in Table 2. They show a mean 
value of 4.08 ___ 1.97 x 10 6 min -1 .  When these are com- 
pared with normal  values registered in a series of 22 
normal  subjects with an upper age limit of 60 years 
(2.7-t-0.8 x 10 .6  min-~) ,  the difference is statistically 
significant (P<0.001).  There were 17 eyes (43%) that 
showed a VFPR higher than the normal  mean _+ 2SD. 
No linear correlation was observed between the initial 
penetrat ion ratios and durat ion of diabetes. 
Correlation between BRB permeability 
and mieroaneurysm gradings at entry 
Classification of the eyes according to microaneurysm 
grading showed 9 eyes at level 0./3 at level 1.7 at level 
2, and 11 at level 3 (Table 3). The VFPR in the 9 eyes 
graded at level 0 was 3.3___/.1 x 10 .6 min -1 ;  in the 13 
eyes graded at level / it was 3.8+_2.0 x 10 .6  min -1 ;  in 
Table 1. Clinical data of the 40 patients 
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Table 2. Vitreous fluorometry results (VFPR, 10-6 min-1) 
No.  Age Sex Duration Initial 
(years) VFPR 
VFPR difference VFPR Difference 
0-12months 0Myears 
1 57 F 11 8.27 
2 58 F 20 4.87 
3 43 M 10 2.94 
4 60 M 6 7.72 
5 47 F 8 4.01 
6 53 M 5 3.40 
7 61 M 10 11.22 
8 60 F 14 2.95 
9 57 F 6 4.60 
10 53 M 10 5.10 
11 45 M 14 5.22 
12 58 M 10 6.32 
13 48 M 8 4.90 
14 65 F 15 3.26 
15 60 M 25 2.32 
16 64 F 10 4.56 
17 64 M 22 2.35 
18 60 F 12 5.80 
19 42 F 5 3.21 
20 56 F 7 4.63 
21 53 F 12 1.86 
22 44 M 5 1.85 
23 59 M I t  2.71 
24 53 F 7 2.07 
25 52 M 14 3.53 
26 44 M 5 3.71 
27 60 M 15 1.91 
28 52 F 9 4.72 
29 43 F 9 5.73 
30 40 F 10 3.12 
31 45 M 4 3.74 
32 55 M 9 1.49 
33 58 F 9 4.93 
34 65 F 5 1.45 
35 47 F 5 5.92 
36 56 M 10 3.67 
37 42 F 5 3.97 
38 61 F 6 4.79 
39 61 F 8 2.72 
40 53 M 10 1.78 
Mean 53.9 9.4 5.54 3.11 
SD 7.3 1.9 1.97 1.22 
+ 1.74 Photoc. 
- 1 .87  + 1 .33  
- 0.03 + 0.44 
+ 1.27 Photoc. 
-0 .22 Photoc. 
+0.48 -0 .59 
+ 1.30 Photoc. 
+ O.75 - O.29 
+ 0.90 - 1.22 
+2.21 Photoc. 
+0.63 +0.12 
+ 2.00 - 1.67 
+ 2.17 Photoc. 
+ 2.20 + 1.00 
+ 0.05 - 1.08 
+ 2.04 Photoc. 
+0.65 -0 .50  
+ 2.24 Photoc. 
-0 .62 -0 .97 
+ 1.27 Photoc. 
+1.54 +2.19 
+ 2.O5 - 0.26 




- 0.50 + 1.05 
+ 2.07 Photoc. 
+2.34 Photoc. 
+ 1.66 + 1.75 
+ 0.49 - 0.42 
+ t.42 - 0.79 
+ 0.38 Photoc. 
+0.18 +O.35 
+ 1.83 Photoc. 
+ 0.12 Photoe. 
+0.36 -0 .47 
+ 2.06 Photoc. 
-0 .48 +0.80 
+0.59 +0.05 
1.54 0.45 0.02 
1.72 0.99 +0.98 
the 7 eyes graded at  level 2 it was  5 .2+ 1.4 ]0  .6  min -  1; 
in the 11 eyes graded at  level 3 it was  4.3___2.6 
10 -6  min -< The  eyes grouped at  level 2, showing  5 -10  
microaneurysms,  had  a s ign i f i cant ly  h igher  level o f  a l ter-  
a t ion  o f  the  BRB,  us ing  ana lys i s  o f  var iance ,  than  level 
0 or  1 (P= 0.027). 
Evolution of BRB permeability and angiography gradings 
in 1 year 
One year  in to  the s tudy  none  o f  the  eyes fo l lowed had  
rece ived photocoagu la t ion .  The  v i t reous  f luoresce in  pen-  
e t ra t ion  ra t ios  inc reased  dur ing  the in i t ia l  12 months  o f  
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Table 3. Microaneurysm gradings 
No. Grading 
Initial 1 year 4 years 
1 1 3 Photocoagulation 
2 0 2 2 
3 0 0 0 
4 2 2 Photocoagulation 
5 3 3 Photocoagulation 
6 0 1 1 
7 3 3 Photocoagulation 
8 1 1 2 
9 0 1 3 
10 3 3 Photocoagulation 
11 2 2 2 
12 1 1 0 
13 3 2 Photocoagulation 
14 2 1 2 
15 1 1 1 
16 3 3 Photocoagulation 
17 3 2 2 
18 2 2 Photocoagulation 
19 1 1 1 
20 3 3 Photocoagulation 
21 1 1 2 
22 0 1 2 
23 3 3 Photocoagulation 
24 3 3 3 
25 0 1 0 
26 0 0 0 
27 1 1 0 
28 3 3 Photocoagulation 
29 2 3 Photocoagulation 
30 1 0 0 
31 1 2 3 
32 3 3 3 
33 2 2 Photocoagulation 
34 1 ~ / 
35 1 2 Photocoagulation 
36 1 3 Photocoagulation 
37 2 3 3 
38 1 1 Photocoagutation 
39 0 0 2 
40 0 0 0 
follow-up as shown in Table 2 (+0.84+1.1 
× 10 -6  rain- 1 ;). Thirty-three yes (83%) showed an in- 
crease in VFPR. After the 1st year of follow-up there 
were increased numbers of microaneurysms that resulted 
in a change of grading in only ten eyes (25%). In four 
patients the angiographic examination showed a de- 
creased number of microaneurysms resulting in a de- 
crease in grading (10%). The remaining 26 eyes (65%) 
remained stabilized. 
BRB permeability and angiography gradings after 4 years 
Sixteen of the 40 diabetic patients (40%) with diabetes 
type 2, who at entry had minimal or no retinopathy 
changes, had received photocoagulation treatment when 
reexamined 4 years after the initial examination (Ta- 
ble 2). Of the 16 eyes that underwent photocoagulation, 
11 received focal treatment, and the remaining 5received 
panretinal photocoagulation. 
The 24 eyes that did not need photocoagulation 
showed that the VFPR values had remained stabilized, 
showing an increase of only 0.02 + 0.98 x 10- 6 min- 1 ; 
over the 4-year period. 
Examination of the initial fluorophotometric values 
shows that the eyes that progressed to photocoagulation 
had clearly higher initial VFPR and more marked alter- 
ation of the BRB than the eyes that did not need photo- 
coagulation (5.5 +_ 2.0 x /0  .6 min-  1 in the eyes that were 
later photocoagulated; 3.1_+1.2 x 10 .6 min -1 in the 
eyes that did6 not need photocoagulation; P<0.001). 
Furthermore, the eyes that needed photocoagulation 
within the 4-year period of follow-up showed a more 
marked increase in vitreous fluorometry values during 
the 1st year than the eyes that did not need photocoagu- 
lation (+ 1.54___0.72 x 10 .6 min -~ in the eyes that were 
later photocoagulated; +0.45_+0.99 x 10 -6 rain - t  in 
the eyes that did not need photocoagulation; P < 0.001). 
The 4-year examination of the 24 patients who did 
not need photoeoagulation showed an advance in micro- 
aneurysm grading during this period in only 9 eyes 
(37%). The grading dropped in 4 eyes ( /7%) and re- 
mained stable in 1/(46%). 
No correlation could be found between change in 
gradings in the 1st year and later need for photocoagula- 
tion. For example, of the ten eyes in which microaneur- 
ysm grading went up during the 1st year, only four later 
needed photocoagulation, whereas the other six did not. 
A higher microaneurysm grading at entry was observed 
more frequently in eyes that later needed photocoagula- 
tion, but this finding did not reach statistical signifi- 
cance. Eight of the /6 eyes were graded at level 3, four 
at level 2, and another four at level 1. 
Discussion 
The present 4-year follow-up study was undertaken to 
establish whether there is a correlation between the BRB 
permeability and the clinical course of retinopathy in 
type 2 diabetes mellitus; evaluation of the course was 
defined according to the need for photocoagulation fol- 
lowing preestablished guidelines. Only eyes with moder- 
ate or no retinopathy were included and the known du- 
ration of diabetes was generally between 4 and 10 years 
(95%). The diabetic patients included in the study had 
blood pressure within normal limits and were under ac- 
ceptable good metabolic ontrol. 
The study showed that there is a positive correlation 
between high BRB permeability and a need for photo- 
coagulation, even among patients with the same retinal 
morphology. A positive correlation was also registered 
between faster ates of increase in BRB permeability dur- 
ing the 1 st year of follow-up and future need for photo- 
coagulation. 
At the end of the 4-year period of follow-up, 16 of 
the 40 study eyes had received photocoagulation, of the 
focal type in 1/ and panretinal in 5. These eyes had 
higher fluorometric values for BRB permeability at entry 
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into the study and presented faster ates of deterioration 
of the BRB during the 1st year of follow-up. 
The study did not show any clear correlation between 
alteration of the BRB and age at entry into the study 
or duration of diabetes, possibly because of the homoge- 
neity of this group of patients. 
Microaneurysm grading on fluorescein angiography 
was chosen as the representative parameter for changes 
in retinal morphology, considering that only eyes with 
a retinopathy of less than level 3 of the modified Airlie 
House Classification were included in the study. The 
microaneurysm gradings remained stable in 50% of the 
study eyes during the 1st year of the study, and thus 
appear to be less effective than BRB permeability quanti- 
fication for recording progression of retinal damage in 
short periods of follow-up. 
No clear difference was apparent between BRB per- 
meability in eyes with microaneurysm grading levels 1 
and 0. Similarly, only 43% of the eyes included in the 
study had VFPR that were higher than the mean value 
plus two standard deviations of a normal population 
used as control. Our results in this study of type 2 diabet- 
ic patients upport he view that, although an alteration 
of the BRB permeability is an early phenomenon occur- 
ing in the diabetic retina, it is by no means a general 
one. This finding contradicts findings by ourselves [2] 
and confirms tudies by other investigators [9]. 
The overlapping observed between the VFPR in the 
four groups of microaneurysm gradings uggests a cer- 
tain degree of discrepancy between BRB permeability 
and retinal morphology, at least in the initial stages of 
diabetic retinopathy. It must be realized, however, that 
vitreous fluorometry values represent predominantly the 
fluorescein leakage occurring in the macular egion [4], 
and that may also be modified by the presence of various 
degrees of capillary closure. 
"Need for focal photocoagulation " is here synono- 
mous with "occurrence of clinically significant macular 
edema" and "need for panretinal photocoagulation" 
with "disk neovascularization". The rate of occurrence 
of these events in this group of 40 patients with type 
2 diabetes is high compared with previous epidemiologi- 
cal studies [8]. It also suggests that progression to clini- 
cally significant macular edema is much faster in type 2 
than in type 1 diabetes [7]. It must not be forgotten, 
however, that duration of diabetes in type 2 diabetes 
is generally underestimated. Age may also play a role 
in the faster deterioration of the retinal vasculature and 
BRB. 
Most studies aimed at the characterization f BRB 
permeability in the earlier stages of retinopathy have 
been performed in patients with type 1 diabetes. This 
study is the first to report a prospective follow-up of 
the BRB alteration in type 2 diabetes. It confirms gener- 
ally the findings reported in an 8-year follow-up study 
of insulin-dependent (type 1) diabetic patients [7]. Our 
study suggests, however, that in type 2 diabetes there 
is a more rapid deterioration of the BRB, particularly 
in a specific group of patients whose eyes therefore ap- 
pear to be at risk for retinopathy progression. This find- 
ing, if confirmed, is of major importance. It suggests 
that a high BRB permeability is of clinical significance 
for the development of the retinopathy. 
Our study indicates that BRB permeability measured 
by vitreous fluorometry could be used to evaluate the 
degree of retinal damage, especially with respect o the 
need for later photocoagulation treatment. The eyes of 
patients with type 2 diabetes who present higher VFPR 
and faster rates of deterioration of the BRB should be 
followed more closely in order to be treated appropriate- 
ly and at the best moment in time. Eyes with low and 
stable vitreous fluorometry readings need less frequent 
examinations, as they appear to have a much better 
prognosis for retaining ood vision. 
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